Literature DB >> 19326261

Generation and characterization of high affinity humanized fab against hepatitis B surface antigen.

Ashutosh Tiwari1, Durgashree Dutta, Navin Khanna, Subrat K Acharya, Subrata Sinha.   

Abstract

5S is a mouse monoclonal IgG1 that binds to the 'a' epitope of the Hepatitis B surface antigen (HBsAg) and tested positive in an in vitro test for virus neutralization. We have earlier reported the generation of humanized single chain variable fragment (scFv) from the same. In this article we report the generation of a recombinant Fab molecule by fusing humanized variable domains of 5S with the constant domains of human IgG1. The humanized Fab expressed in E. coli and subsequently purified, retained a high binding affinity (K(D) = 3.63 nmol/L) to HBsAg and bound to the same epitope of HBsAg as the parent molecule. The humanized Fab also maintained antigen binding in the presence of various destabilizing agents like 3 M NaCl, 30% DMSO, 8 M urea, and extreme pH. This high affinity humanized Fab provides a basis for the development of therapeutic molecules that can be safely utilized for the prophylaxis and treatment for Hepatitis B infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19326261     DOI: 10.1007/s12033-009-9165-9

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  56 in total

Review 1.  Antibody and virus: binding and neutralization.

Authors:  D R Burton; R A Williamson; P W Parren
Journal:  Virology       Date:  2000-04-25       Impact factor: 3.616

2.  Characterization and molecular modeling of a highly stable anti-Hepatitis B surface antigen scFv.

Authors:  Biplab Bose; Dipti A Chugh; Mrinalini Kala; Subrat K Acharya; Navin Khanna; Subrata Sinha
Journal:  Mol Immunol       Date:  2003-12       Impact factor: 4.407

3.  Humanization of high affinity anti-HBs antibody by using human consensus sequence and modification of selected minimal positional template and packing residues.

Authors:  Ashutosh Tiwari; Navin Khanna; Subrat K Acharya; Subrata Sinha
Journal:  Vaccine       Date:  2009-02-13       Impact factor: 3.641

4.  Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance.

Authors:  L J Cooper; D Robertson; R Granzow; N S Greenspan
Journal:  Mol Immunol       Date:  1994-06       Impact factor: 4.407

Review 5.  IgG effector mechanisms.

Authors:  M R Clark
Journal:  Chem Immunol       Date:  1997

6.  Complete variable region sequence of a nonfunctionally rearranged kappa light chain transcribed in the nonsecretor P3-X63-Ag8.653 myeloma cell line.

Authors:  R Strohal; G Kroemer; G Wick; R Kofler
Journal:  Nucleic Acids Res       Date:  1987-03-25       Impact factor: 16.971

7.  Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine.

Authors:  M C Honorati; R M Borzì; P Dolzani; S Toneguzzi; A Facchini
Journal:  Int J Clin Lab Res       Date:  1997

8.  Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity.

Authors:  C F Barbas; J E Crowe; D Cababa; T M Jones; S L Zebedee; B R Murphy; R M Chanock; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  Designing human consensus antibodies with minimal positional templates.

Authors:  J R Couto; R B Christian; J A Peterson; R L Ceriani
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

10.  A recombinant Fab neutralizes dengue virus in vitro.

Authors:  P Thullier; P Lafaye; F Mégret; V Deubel; A Jouan; J C Mazié
Journal:  J Biotechnol       Date:  1999-04-15       Impact factor: 3.307

View more
  2 in total

1.  A repertoire of high-affinity monoclonal antibodies specific to S. typhi: as potential candidate for improved typhoid diagnostic.

Authors:  Chandresh Sharma; Anurag Sankhyan; Tarang Sharma; Naeem Khan; Susmita Chaudhuri; Niraj Kumar; Shinjini Bhatnagar; Navin Khanna; Ashutosh Tiwari
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

Review 2.  Phage display creates innovative applications to combat hepatitis B virus.

Authors:  Wen Siang Tan; Kok Lian Ho
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.